• Sab. Mar 14th, 2026

CRISPR-Cas9

  • Home
  • California grants $7.4 million to advance gene-edited stem cell therapy for Friedreich’ s ataxia

California grants $7.4 million to advance gene-edited stem cell therapy for Friedreich’ s ataxia

The California Institute for Regenerative Medicine (CIRM) has awarded $7.4 million to support a University of California San Diego team developing a first-of-its-kind stem cell-based gene therapy for Friedreich’s ataxia,…

Immune Cells Identified as Key Players in Brain Health

Using novel genetic and genomic tools, researchers at the Icahn School of Medicine at Mount Sinai have shed light on the role of immune cells called macrophages in lipid-rich tissues…